Ivabradine 5mg and 7.5mg film-coated tablets
(Ivabradine)
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it onto others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
- Ivabradine 5 mg and 7.5mg film-coated tablets are known as Ivabradine film-coated tablets in this leaflet.
1. What Ivabradine film-coated tablets are and what they are used for
2. What you need to know before you take Ivabradine film-coated tablets
3. How to take Ivabradine film-coated tablets
4. Possible side effects
5. How to store Ivabradine film-coated tablets
6. Contents of the pack and other information
Ivabradine is a heart medicine used to treat:
- Symptomatic stable angina pectoris (which causes chest pain) in adult patients whose heart rate is over or equal to 70 beats per minute. It is used in adult patients who do not tolerate or cannot take heart medicines called beta-blockers. It is also used in combination with beta-blockers in adult patients whose condition is not fully controlled with a beta-blocker.
- Chronic heart failure in adult patients whose heart rate is over or equal to 75 beats per minute. It is used in combination with standard therapy, including beta- blocker therapy or when beta-blockers are contraindicated or not tolerated.
About stable angina pectoris (usually referred to as “angina”):
Stable angina is a heart disease which happens when the heart does not receive enough oxygen. The most common symptom of angina is chest pain or discomfort.
About chronic heart failure:
Chronic heart failure is a heart disease which happens when your heart cannot pump enough blood to the rest of your body. The most common symptoms of heart failure are breathlessness, fatigue, tiredness and ankle swelling.
How does this medicine work
The specific heart rate lowering action of ivabradine helps:
- to control and reduce the number of angina attacks by lowering the heart's need for oxygen,
- to improve the heart functioning and vital prognosis in patients with chronic heart failure.
- if you are allergic to ivabradine or any of the other ingredients of this medicine (listed in section 6);
- if your resting heart rate before treatment is too slow (below 70 beats per minute);
- if you are suffering from cardiogenic shock (a heart condition treated in hospital);
- if you suffer from a heart rhythm disorder (sick sinus syndrome, sino-atrial block, 3rd-degree AV block);
- if you are having a heart attack;
- if you suffer from very low blood pressure;
- if you suffer from unstable angina (a severe form in which chest pain occurs very frequently and with or without exertion);
- if you have heart failure which has recently become worse;.
- if your heartbeat is exclusively imposed by your pacemaker;
- if you suffer from severe liver problems;
- if you are already taking medicines for the treatment of fungal infections (such as ketoconazole, itraconazole), macrolide antibiotics (such as josamycin, clarithromycin telithromycin or erythromycin given orally), medicines to treat HIV infections (such as nelfinavir, ritonavir) or nefazodone (medicine to treat depression) or diltiazem, verapamil (used for high blood pressure or angina pectoris);
- if you are a woman able to have children and not using reliable contraception;
- if you are pregnant or trying to become pregnant;
- if you are breast-feeding
Talk to your doctor or pharmacist before taking Ivabradine film-coated tablets
- if you suffer from heart rhythm disorders (such as irregular heartbeat, palpitation, increase in chest pain) or sustained atrial fibrillation (a type of irregular heart- beat), or an abnormality of electrocardiogram (ECG) called 'long QT syndrome';
- if you have symptoms such as tiredness, dizziness or shortness of breath (this could mean that your heart is slowing down too much);
- if you suffer from symptoms of atrial fibrillation (pulse rate at rest unusually high (over 110 beats per minute) or irregular, without any apparent reason, making it difficult to measure);
- if you have had a recent stroke (cerebral attack);
- if you suffer from mild to moderate low blood pressure;
- if you suffer from uncontrolled blood pressure, especially after a change in your antihypertensive treatment;
- if you suffer from severe heart failure or heart failure with abnormality of ECG called 'bundle branch block';
- if you suffer from chronic eye retinal disease,
- if you suffer from moderate liver problems,
- if you suffer from severe renal problems.
If any of the above applies to you, talk straight away to your doctor before or while taking this medicine.
Ivabradine film-coated tablets is not intended for use in children and adolescents younger than 18 years.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of Ivabradine film-coated tablets or monitoring should be required:
- fluconazole (an antifungal medicine);
- rifampicin (an antibiotic);
- barbiturates (for difficult sleeping or epilepsy);
- phenytoin (for epilepsy);
- Hypericum perforatum or St John's Wort (herbal treatment for depression)
- QT prolonging medicines to treat either heart rhythm disorders or other conditions
- quinidine, disopyramide, ibutilide, sotalol, amiodarone (to treat heart rhythm disorders);
- bepridil (to treat angina pectoris);
- certain types of medicines to treat anxiety, schizophrenia or other psychoses (such as pimozide, ziprasidone, sertindole);
- anti-malarial medicines (such as mefloquine or halofantrine);
- intravenous erythromycin (an antibiotic);
- pentamidine (an antiparasitic medicine);
- cisapride (against the gastro-oesophageal reflux);
- Some types of diuretics which may cause decrease in blood potassium level, such as furosemide, hydrochlorothiazide, indapamide (used to treat oedema, high blood pressure).
Avoid grapefruit juice during treatment with this medicine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Ivabradine film-coated tablets if you are pregnant or are planning to have a baby (see “Do not take Ivabradine film-coated tablets”).
If you are pregnant and have taken Ivabradine film-coated tablets, talk to your doctor.
Do not take Ivabradine film-coated tablets if you are able to become pregnant unless you use reliable contraceptive measures (see “Do not take Ivabradine film-coated tablets”).
Do not take Ivabradine film-coated tablets if you are breast-feeding (see “Do not take Ivabradine film-coated tablets”). Talk to your doctor if you are breast-feeding or intending to breast-feed as breastfeeding should be discontinued if you take Ivabradine film-coated tablets
Ivabradine film-coated tablets may cause temporary luminous visual phenomena (a temporary brightness in the field of vision, see “Possible side effects”). If this happens to you, be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say it is essentially 'sodium free'.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Ivabradine film-coated tablets should be taken during meals.
If you are being treated for stable angina pectoris
The starting dose should not exceed one tablet of Ivabradine film-coated tablets 5 mg twice daily. If you still have angina symptoms and if you have tolerated the 5 mg twice daily dose well, the dose may be increased. The maintenance dose should not exceed 7.5 mg twice daily. Your doctor will prescribe the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are aged 75 years or more), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Ivabradine film-coated tablets 5 mg (corresponding to 2.5 mg ivabradine) in the morning and one half 5 mg tablet in the evening.
If you are being treated for chronic heart failure
The usual recommended starting dose is one tablet of Ivabradine 5mg film-coated tablets twice daily increasing if necessary to one tablet of Ivabradine 7.5mg film-coated tablets twice daily. Your doctor will decide the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are aged 75 years or more), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Ivabradine film-coated tablets 5 mg (correspond- ing to 2.5 mg ivabradine) in the morning and one half 5 mg tablet in the evening.
A large dose of Ivabradine film-coated tablets could make you feel breathless or tired because your heart slows down too much. If this happens, contact your doctor immediately.
If you forget to take a dose of Ivabradine film-coated tablets, take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose.
As the treatment for angina or chronic heart failure is usually life-long, you should discuss with your doctor before stopping this medicinal product.
If you think that the effect of Ivabradine film-coated tablets is too strong or too weak, talk to your doctor or pharmacist.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common adverse reactions with this medicine are dose dependent and related to its mode of action:
Very common (may affect more than 1 in 10 people)
Luminous visual phenomena (brief moments of increased brightness, most often caused by sudden changes in light intensity). They can also be described as a halo, coloured flashes, image decomposition or multiple images. They generally occur within the first two months of treatment after which they may occur repeatedly and resolve during or after treatment.
Common (may affect up to 1 in 10 people)
Modification in the heart functioning (the symptoms are a slowing down of the heart rate). They particularly occur within the first 2 to 3 months of treatment initiation.
Common (may affect up to 1 in 10 people)
lrregular rapid contraction of the heart (atrial fibrillation), abnormal perception of heartbeat (bradycardia, ventricular extrasystoles, 1st-degree AV block (ECG prolonged PQ interval)), uncontrolled blood pressure, headache, dizziness and blurred vision (cloudy vision).
Uncommon (may affect up to 1 in 100 people)
Palpitations and cardiac extra beats, feeling sick (nausea), constipation, diarrhoea, abdominal pain, spinning sensation (vertigo), difficulty breathing (dyspnoea), muscle spasms, high blood levels of uric acid, an excess of eosinophils (a type of white blood cell) and elevated creatinine in blood (a breakdown product of muscle), skin rash, angioedema (such as swollen face, tangue or throat, difficulty in breathing or swallowing), low blood pressure, fainting, feeling of tiredness, feeling of weakness, abnormal ECG heart tracing, double vision, impaired vision.
Rare (may affect up to 1 in 1,000 people)
Urticaria, itching, skin reddening, feeling unwell.
Very rare (may affect up to 1 in 10,000 people)
lrregular heartbeats (2nd-degree AV black, 3rd-degree AV black, sick sinus syndrome).
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. Vou can also report side effects directly via the Yellow Gard Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Gard in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after `EXP'. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is ivabradine (as hydrochloride).
Ivabradine 5 mg: Each film-coated tablet contains 5 mg ivabradine (as hydrochloride).
Ivabradine 7.5 mg: Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride).
The other ingredients are:
Tablet core
Lactose monohydrate, Cellulose microcrystalline, Croscarmellose sodium, Silica colloidal anhydrous, Magnesium stearate
Coating
Hypromellose (E464), Titanium dioxide (E171), Macrogol 6000 (E1521), Magnesium stearate (E470b), Glycerol (E422).
Ivabradine 5 mg: white colored, oval shape, biconvex, film coated tablet scored and engraved with '5' at one side, plain on the other. The tablet can be divided into equal doses.
Ivabradine 7.5 mg: white colored, round, biconvex, film coated tablet, engraved with '7.5' at one side and plain on the other.
The tablets are available in (Aluminium/aluminium blisters) of 14, 28, 56, 84, 98, 100 or 112 tablets.
Not all pack sizes may be marketed.
Flamingo Pharma (UK) Ltd.
First Floor
Kirkland House
11-15 Peterborough Road
Harrow
Middlesex
HA1 2AX
United Kingdom
Genepharm S.A.
18 km Marathon Avenue
153 51 Pallini Attikis
Greece
Flamingo Pharma (UK) Ltd.
The Bloc
38 Springfield Way
Anlaby
Hull
HU 10 6RJ
United Kingdom
Marketing authorisation Number:
PL 43461/0174
PL 43461/0175
This leaflet was last revised in 11/2025
POM
MPLLIVAXXXXTBCOM
FPLXXX448V01_A